Garner, R E; Domer, J E (1994) Lack of effect of Candida albicans mannan on development of protective immune responses in experimental murine candidiasis. Infect Immun 62:738-41
|
Domer, J E; Human, L G; Andersen, G B et al. (1993) Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A. Infect Immun 61:2122-30
|
Garner, R E; Kuruganti, U; al-Hussaini, L A et al. (1992) Effect of in vivo administration of recombinant murine gamma interferon on in vitro lymphoproliferative responses following immunization with Candida albicans. Infect Immun 60:1927-35
|
Garner, R E; Childress, A M; Human, L G et al. (1990) Characterization of Candida albicans mannan-induced, mannan-specific delayed hypersensitivity suppressor cells. Infect Immun 58:2613-20
|
Garner, R E; Kuruganti, U; Czarniecki, C W et al. (1989) In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon. Infect Immun 57:1800-8
|
Domer, J E; Garner, R E; Befidi-Mengue, R N (1989) Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI. Infect Immun 57:693-700
|
Bennett, J W; Henderberg, A; Grossman, K (1989) Sterigmatocystin production on complex and defined substrates. Mycopathologia 105:35-8
|
Henderberg, A; Bennett, J W; Lee, L S (1988) Biosynthetic origin of aflatoxin G1: confirmation of sterigmatocystin and lack of confirmation of aflatoxin B1 as precursors. J Gen Microbiol 134:661-7
|
Kuruganti, U; Henderson, L A; Garner, R E et al. (1988) Nonspecific and Candida-specific immune responses in mice suppressed by chronic administration of anti-mu. J Leukoc Biol 44:422-33
|
Domer, J E; Hector, R F (1987) Enhanced immune responses in mice treated with penicillin-tetracycline or trimethoprim-sulfamethoxazole when colonized intragastrically with Candida albicans. Antimicrob Agents Chemother 31:691-7
|
Showing the most recent 10 out of 14 publications